Literature DB >> 11112452

Intracellular signaling factors--enhanced hepatic nuclear protein binding to TTGGC sequence in the rat regucalcin gene promoter: involvement of protein phosphorylation.

H Misawa1, M Yamaguchi.   

Abstract

The transcriptional mechanism of regucalcin gene expression was determined using gel mobility shift assay with TTGGC oligonucleotide (II-b) which is located between position -523 and -506 in the promoter region, containing a nuclear factor I (NF1) consensus motif TTGGC(N)(6)CC. The mutation analysis in this motif showed that TTGGC sequence was a specific binding region of the nuclear protein in rat liver and the cloned rat hepatoma cells (H4-II-E). When liver nuclei were incubated with ATP (1 mM), the nuclear protein binding to TTGGC sequence was increased. This binding was also increased in the nuclei of H4-II-E cells cultured with 10% FBS. Such an increase was also seen by culture with vanadate (100 microM), a potent inhibitor of protein tyrosine phosphatase. Serum-enhanced nuclear protein binding to TTGGC sequence was decreased in the presence of TFP (10 microM), staurosporine (100 nM), genistein (10 microM), PD98059 (10 microM), or wortmannin (10 nM), which are inhibitors of various protein kinases. Treatment of a monoclonal phosphotyrosine antibody (4G10) caused an alteration in the TTGGC oligonucleotide-nuclear protein complex formation, indicating that tyrosine phosphorylation of nuclear protein is partly involved in the binding to TTGGC sequence. Moreover, when H4-II-E cells were cultured with FBS (10%), Bay K 8644 (5 microM), PMA (1 microM), or insulin (20 nM), the protein binding to TTGGC sequence in the nuclei was increased, while it was reduced in the cytoplasm, indicating a nuclear localization of the TTGGC sequence-binding protein. This study demonstrates that hepatic nuclear protein can specifically bind to the TTGGC sequence in rat regucalcin gene promoter region, and that this binding is enhanced by intracellular signaling factors which are partly mediated through protein phosphorylation. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11112452     DOI: 10.1006/bbrc.2000.3934

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Potential role of regucalcin as a specific biochemical marker of chronic liver injury with carbon tetrachloride administration in rats.

Authors:  Masayoshi Yamaguchi; Yoshinori Tsurusaki; Hiroyuki Misawa; Shyuichiroh Inagaki; Zhong Jie Ma; Hiroko Takahashi
Journal:  Mol Cell Biochem       Date:  2002-12       Impact factor: 3.396

Review 2.  Regucalcin and metabolic disorders: osteoporosis and hyperlipidemia are induced in regucalcin transgenic rats.

Authors:  Masayoshi Yamaguchi
Journal:  Mol Cell Biochem       Date:  2010-03-28       Impact factor: 3.396

3.  Activatory effect of regucalcin on GTPase activity in rat liver plasma membranes.

Authors:  H Takahashi; M Yamaguchi
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

4.  The transcriptional regulation of regucalcin gene expression.

Authors:  Masayoshi Yamaguchi
Journal:  Mol Cell Biochem       Date:  2010-10-11       Impact factor: 3.396

Review 5.  Regucalcin and cell regulation: role as a suppressor protein in signal transduction.

Authors:  Masayoshi Yamaguchi
Journal:  Mol Cell Biochem       Date:  2011-03-24       Impact factor: 3.396

6.  Involvement of regucalcin gene promoter region-related protein-p117, a transcription factor, in human obesity.

Authors:  Masayoshi Yamaguchi; Tomiyasu Murata
Journal:  Biomed Rep       Date:  2017-03-17

Review 7.  Novel protein RGPR-p117: its role as the regucalcin gene transcription factor.

Authors:  Masayoshi Yamaguchi
Journal:  Mol Cell Biochem       Date:  2009-02-12       Impact factor: 3.396

8.  Sp1/3 and NF-1 mediate basal transcription of the human P2X1 gene in megakaryoblastic MEG-01 cells.

Authors:  Jiangqin Zhao; Steven J Ennion
Journal:  BMC Mol Biol       Date:  2006-03-10       Impact factor: 2.946

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.